SCHEMBL15928995

SCHEMBL15928995

O=C(OCCCCO[N+](=O)[O-])c1ccc(N=Nc2ccc(-c3cc(=S)ss3)cc2)cc1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.39
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA4 P22748 3/20 0.39
CA9 Q16790 3/20 0.39
HDAC3 O15379 9/20 0.38
HDAC4 P56524 9/20 0.38
HDAC1 Q13547 9/20 0.38
HDAC7 Q8WUI4 9/20 0.38
HDAC2 Q92769 9/20 0.38
HDAC10 Q969S8 9/20 0.38
HDAC11 Q96DB2 9/20 0.38
HDAC8 Q9BY41 9/20 0.38
HDAC6 Q9UBN7 9/20 0.38
HDAC9 Q9UKV0 9/20 0.38
HDAC5 Q9UQL6 9/20 0.38
TDP1 Q9NUW8 2/20 0.34
SERPINE1 P05121 1/20 0.34
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15928880 0.93 PTGS2 (0.39) PTGS2CA12CA1CA2CA4
SCHEMBL15928945 0.87 PTGS2 (0.53) PTGS2CA12CA1CA2CA4
SCHEMBL15928881 0.85 PTGS2 (0.53) PTGS2CA12CA1CA2CA4
SCHEMBL596371 0.75 MEN1 (0.51) PTGS2CA12CA1CA2CA9
SCHEMBL596372 0.75 MEN1 (0.51) PTGS2CA12CA1CA2CA9
SCHEMBL15928871 0.75 PTGS2 (0.56) PTGS2CA12CA1CA2CA4
SCHEMBL15928879 0.74 PTGS2 (0.42) PTGS2CA12CA1CA2CA4
SCHEMBL15928893 0.73 PTGS2 (0.54) PTGS2CA12CA1CA2CA4
SCHEMBL15928865 0.73 PTGS2 (0.53) PTGS2CA12CA1CA2CA4
SCHEMBL15928938 0.73 PTGS2 (0.42) PTGS2CA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450260-B2 NO- and H2S-releasing compounds RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2019-10-22 US disclosed
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK 2017-09-14 US disclosed
US-9688607-B2 No- and H2S-releasing compounds RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2017-06-27 US disclosed
US-20140221316-A1 NO- AND H2S- RELEASING COMPOUNDS RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221316-A1 NO- AND H2S- RELEASING COMPOUNDS PTGS1, NOS2, NOS1 PTGS2 4/4885CA12 3042/4885CA1 1550/4885
US-20170260124-A1 NO- AND H2S- RELEASING COMPOUNDS NOS2, NOS3, NOS1 PTGS2 9/4885CA12 2261/4885CA1 2153/4885
US-10450260-B2 NO- and H2S-releasing compounds NOS2, NOS3, NOS1 PTGS2 9/4885CA12 2261/4885CA1 2153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.